HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines.

about

HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines.

Item

http://www.wikidata.org/entity/Q50643855

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HER2 positivity may confer res ...... l in breast cancer cell lines.

@en

HER2 positivity may confer res ...... l in breast cancer cell lines.

@nl

type

Item

label

HER2 positivity may confer res ...... l in breast cancer cell lines.

@en

HER2 positivity may confer res ...... l in breast cancer cell lines.

@nl

prefLabel

HER2 positivity may confer res ...... l in breast cancer cell lines.

@en

HER2 positivity may confer res ...... l in breast cancer cell lines.

@nl

P1476

HER2 positivity may confer res ...... l in breast cancer cell lines.

@en

P2093

Behzad Baradaran

http://www.w3.org/2001/XMLSchema#string

Daniel Elieh Ali Komi

http://www.w3.org/2001/XMLSchema#string

Dariush Shanehbandi

http://www.w3.org/2001/XMLSchema#string

Faezeh Asghari

http://www.w3.org/2001/XMLSchema#string

Navideh Haghnavaz

http://www.w3.org/2001/XMLSchema#string

Tohid Kazemi

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs and their target gene networks in breast cancer

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

MicroRNA gene expression deregulation in human breast cancer

Prognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studies

Micro-RNA profiling in kidney and bladder cancers

MicroRNA signatures in human ovarian cancer

Causes and consequences of microRNA dysregulation in cancer

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.

P304

518-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21691401.2017.1326927

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28509576

http://www.w3.org/2001/XMLSchema#string